RAC - Charts & Price Action, page-16160

I think we need to classify "Heyline" to our resident conspiracy theorist.

There's been a ton of Speculation on the forum, all good and to be expected. But i find it very difficult to find an ounce of truth in your posts.

Since when do these "other directors" have a lazy attitude towards their job and want to accept $10? (Let alone get a say in what is offered)

JC has actually been leading some of the meetings with DCB in the USA, when meeting with Clinical advisors and trying to form the strategy to commercialization.

Who care's if Phil & T were mates, who cares why Tillet left, He's comfortable leaving 16m shares in the hands of management, COH collaboration is nearly a done deal, DCB is speaking to multiple pharma and employing experts. I don't know how many times he's said he's excited to outline a clear path and strategy to commercialization in July/Aug, including updating us on where things are at right now.